Featured Research

from universities, journals, and other organizations

Boost In Immune Response Fights Common Cold

Date:
April 24, 2005
Source:
USDA/Agricultural Research Service
Summary:
Nursing facility residents who consumed 200 International Units (IUs) of vitamin E daily for one year were less likely to get the sniffles than those who took a placebo. Scientists funded by the Agricultural Research Service (ARS) found that those who took the moderate supplements were 20 percent less likely to contract upper respiratory infections, such as colds.

In immune system studies on the elderly, participants who received 200 international units of vitamin E daily for 1 year were 20 percent less likely to suffer from upper respiratory infections, such as colds, than those who received placebos.
Credit: Photo by Ken Hammond

Nursing facility residents who consumed 200 International Units (IUs) of vitamin E daily for one year were less likely to get the sniffles than those who took a placebo. Scientists funded by the Agricultural Research Service (ARS) found that those who took the moderate supplements were 20 percent less likely to contract upper respiratory infections, such as colds.

The study was led by Simin Nikbin Meydani, director of the Nutritional Immunology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University in Boston, Mass. The findings are important because, due to aging, the elderly have lowered immune responses and incur greater health risks from upper respiratory infections.

The scientists studied 617 people over 65 years of age who met the study's eligibility requirements. All 451 participants who completed the study were residents in some type of long-term-care nursing facility located in or around the Boston area.

About half of the participants were given the daily dose of 200 IUs of vitamin E; the remaining participants received a daily placebo capsule containing only four IUs of vitamin E. To help control other dietary factors that affect immune response, all participants received a capsule containing 50 percent of the recommended dietary allowance for essential micronutrients. Each volunteer was examined for health status on a weekly basis.

Good dietary sources of vitamin E include certain cereals, wheat germ, nuts--especially sunflower seeds and almonds--leafy green vegetables and vegetable oils. The National Academy of Sciences has set an upper tolerable limit for vitamin E of 1,500 IUs a day.

The study results were published in The Journal of the American Medical Association.


Story Source:

The above story is based on materials provided by USDA/Agricultural Research Service. Note: Materials may be edited for content and length.


Cite This Page:

USDA/Agricultural Research Service. "Boost In Immune Response Fights Common Cold." ScienceDaily. ScienceDaily, 24 April 2005. <www.sciencedaily.com/releases/2005/04/050421234259.htm>.
USDA/Agricultural Research Service. (2005, April 24). Boost In Immune Response Fights Common Cold. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/04/050421234259.htm
USDA/Agricultural Research Service. "Boost In Immune Response Fights Common Cold." ScienceDaily. www.sciencedaily.com/releases/2005/04/050421234259.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins